Stanford University
Showing 21-40 of 106 Results
-
Pieter van der Starre
Professor of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsCardiovascular Pharmacology, Cardiovascular Physiology,
Neurophysiology and Monitoring,
Transesophageal Echocardiography -
Keith Van Haren, MD
Assistant Professor of Neurology (Pediatric Neurology) and of Pediatrics
Current Research and Scholarly InterestsOur research team is working to develop new treatments for children at risk of neurodegenerative diseases. We are primarily focused on multiple sclerosis and X-linked adrenoleukodystrophy, two conditions that involve inflammatory and metabolic disruption of the myelin that insulates brain cells. A key area of interest for us is how nutrient deficiencies during childhood may contribute to the disease processes and whether nutritional interventions could play a role in prevention.
-
Capucine Van Rechem
Assistant Professor of Pathology (Pathology Research)
Current Research and Scholarly InterestsMy long-term interest lies in understanding the impact chromatin modifiers have on disease development and progression so that more optimal therapeutic opportunities can be achieved. My laboratory explores the direct molecular impact of chromatin-modifying enzymes during cell cycle progression, and characterizes the unappreciated and unconventional roles that these chromatin factors have on cytoplasmic function such as protein synthesis.
-
Peter Johannes van Roessel
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Peter van Roessel, MD PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City, with additional training in psychodynamic psychotherapy (TFP) via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University.
At Stanford, Dr. van Roessel sees adult mood and anxiety disorders outpatients through the Assessment Clinics and participates in resident training and patient care as director of the resident Continuity Clinic and as a supervisor in psychodynamic psychotherapy. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology. As a member of the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and contributes to and leads clinical neuroscience studies pioneering rapid-acting interventions in OCD. Clinically motivated research interests include the nature and neural correlates of metacognitive ‘awareness’ (insight) in OCD and related disorders, and particularly the relationship of awareness to mechanisms of attentional control.
Dr. van Roessel pursued research training in basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. He has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he was a 2020-2022 Miller Foundation Fellow, and from 2020 to 2022 was a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA. Dr. van Roessel is a Fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. -
Benjamin Van Roy
Professor of Electrical Engineering, of Management Science and Engineering
BioBenjamin Van Roy is a Professor at Stanford University, where he has served on the faculty since 1998. His current research focuses on reinforcement learning. Beyond academia, he leads a DeepMind Research team in Mountain View, and has also led research programs at Unica (acquired by IBM), Enuvis (acquired by SiRF), and Morgan Stanley.
He is a Fellow of INFORMS and IEEE and has served on the editorial boards of Machine Learning, Mathematics of Operations Research, for which he co-edited the Learning Theory Area, Operations Research, for which he edited the Financial Engineering Area, and the INFORMS Journal on Optimization. He received the SB in Computer Science and Engineering and the SM and PhD in Electrical Engineering and Computer Science, all from MIT, where his doctoral research was advised by John N. Tstitsiklis. He has been a recipient of the MIT George C. Newton Undergraduate Laboratory Project Award, the MIT Morris J. Levin Memorial Master's Thesis Award, the MIT George M. Sprowls Doctoral Dissertation Award, the National Science Foundation CAREER Award, the Stanford Tau Beta Pi Award for Excellence in Undergraduate Teaching, the Management Science and Engineering Department's Graduate Teaching Award, and the Lanchester Prize. He was the plenary speaker at the 2019 Allerton Conference on Communications, Control, and Computing. He has held visiting positions as the Wolfgang and Helga Gaul Visiting Professor at the University of Karlsruhe, the Chin Sophonpanich Foundation Professor and the InTouch Professor at Chulalongkorn University, a Visiting Professor at the National University of Singapore, and a Visiting Professor at the Chinese University of Hong Kong, Shenzhen. -
Barbara Van Schewick
M. Elizabeth Magill Professor of Law
BioBarbara van Schewick is an Associate Professor of Law and Helen L. Crocker Faculty Scholar at Stanford Law School, Director of Stanford Law School's Center for Internet and Society, and Associate Professor (by courtesy) of Electrical Engineering in Stanford University's Department of Electrical Engineering, and a leading expert on network neutrality.
Van Schewick’s research on the economic, regulatory, and strategic implications of communication networks bridges law, networking and economics. Her Internet Architecture and Innovation (MIT Press 2010) is considered to be the seminal work on the science, economics and policy of network neutrality. Her papers on network neutrality have influenced regulatory debates in the United States, Canada and Europe.
In 2007, van Schewick was one of three academics who, together with public interest groups, filed the petition that started the Federal Communications Commission’s network neutrality inquiry into Comcast’s blocking of BitTorrent and other peer-to-peer protocols. She has testified before the FCC in en banc hearings and she co-authored an amicus brief along with Professors Jack Balkin, Lawrence Lessig, and Tim Wu, among others defending the FCC order that ordered Comcast to stop interfering with BitTorrent.
Prior to joining the Stanford Law faculty, van Schewick was a senior researcher at the Technical University Berlin, and a nonresidential fellow of Stanford Law School’s Center for Internet and Society. From August 2000 to November 2001, she was that Center’s first residential fellow. Van Schewick is on the Advisory Board of Public Knowledge.
Van Schewick holds a PhD in Computer Science, an MSc in Computer Science, and a BSc in Computer Science, all summa cum laude from Technical University Berlin, the Second State Exam in Law (equivalent of Bar Exam), summa cum laude, from the Higher Regional Court Berlin and the First State Exam in Law (equivalent of J.D.), summa cum laude, from Free University Berlin. -
Vance Vanier, M.D.
Clinical Assistant Professor, Emergency Medicine
Current Research and Scholarly InterestsPrimary and secondary prevention of disease through the use of preventive genomic medicine. Patients who have greater insight into their genetic risk for different diseases may change their lifestyles and decrease their probablity of succumbing to conditions such as diabetes and cardiovascular events. Personalized screening regimens for those at increased genetic risk, such as for colon cancer, is another important application worthy of validation.
-
Tiziana Vanorio
Associate Professor of Earth and Planetary Sciences
Current Research and Scholarly InterestsRock Physics, Fossil Energy Exploration, Volcanic and Geothermal Environments and Microseismicity
-
Anubodh Sunny Varshney
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Anubodh Sunny Varshney is a Clinical Assistant Professor in the section of Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford. In addition to caring for patients with advanced heart disease, he is also an Investigator in the Cardiovascular Outcomes, Policy, & Implementation Research Group (https://www.copirgroup.com/) where he works to identify patient groups that have ongoing unmet medical needs, define benchmark outcomes that next generation therapies should improve upon, and understand factors that influence clinical adoption of novel drug and device therapies.
Dr. Varshney earned a BS in biomedical engineering from Washington University in St. Louis and an MD from the University of Texas Southwestern Medical School. He completed residency in Internal Medicine and fellowship in Cardiovascular Medicine at Brigham & Women’s Hospital/Harvard Medical School and fellowship in Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford University.
Dr. Varshney also has experience advising multiple medical device, drug, and digital health start-ups and currently serves as a Venture Advisor at Broadview Ventures, a philanthropically-funded, mission-driven investment organization that invests in early-stage companies developing technologies that have the potential to improve outcomes for patients with cardiovascular disease or stroke.
